United States · FDA National Drug Code directory
Losartan Potassium and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-449_d80ae5dd-3bdc-40a4-9589-dfb7f8eabe6d
- Product NDC
- 46708-449
- Form
- TABLET, FILM COATED
- Composition / generic term
- Losartan Potassium and Hydrochlorothiazide
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160523
- Source listing expiry
- 20261231
Source-listed ingredients
- LOSARTAN POTASSIUM — 100 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (46708-449-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 46708-449-10
- 30 TABLET, FILM COATED in 1 BOTTLE (46708-449-30) · 46708-449-30
- 90 TABLET, FILM COATED in 1 BOTTLE (46708-449-90) · 46708-449-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (46708-449-91) · 46708-449-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →